Bottom line
Is VIVAX a good fund? The bottom line
VIVAX is the Investor share class of Vanguard Value Index Fund, an index large value mutual fund from Vanguard.
Its expense ratio is 0.17% — about $17 a year on every $10,000 invested, cheaper than 94% of large value funds we track.
It returned +15.1% over one year, +12.5% a year over five years, +11.5% a year over ten (as of Dec 31, 2025, per its prospectus).
With $254 billion in net assets and 326 holdings, its largest position is Micron Technology Inc (4.9%) and the top 10 make up 23.6% of the portfolio.
The closest lower-cost alternative we found is SCHV (0.04%, 81% top-holdings overlap).
What stands out
- Low cost: cheaper than 94% of large value peers
- 5-year return beat 72% of category peers
- Broadly diversified (326 holdings)
- No front-end sales load
- Large and established ($254 billion)
Updated Nov 19, 2026
What VIVAX invests in
Vanguard Value ETF, an exchange-traded share class of Vanguard Value Index Fund (the Fund), seeks to track the performance of a benchmark index that measures the investment return of large-capitalization value stocks.
The Fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index (the Target Index), a broadly diversified index made up of the value stocks of large U.S. companies, as determined by the index provider. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the Target Index. The Fund attempts to replicate the Target Index by investing all, or substantially all, of its assets in the stocks that make up the Target Index, holding each stock in approximately the same proportion as its weighting in the Target Index.
From the fund's prospectus (filed Apr 28, 2026).
VIVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| VIVAX | +15.1% | +12.5% | +11.5% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What VIVAX costs
On a $10,000 investment, VIVAX's 0.17% expense ratio costs about $17 a year. The prospectus estimates $217 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
VIVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Micron Technology Inc | 4.87% |
| 2 | JPMorgan Chase & Co | 3.06% |
| 3 | Berkshire Hathaway Inc | 2.95% |
| 4 | Johnson & Johnson | 2.29% |
| 5 | Exxon Mobil Corp | 2.12% |
| 6 | Walmart Inc | 1.86% |
| 7 | Caterpillar Inc | 1.83% |
| 8 | AbbVie Inc | 1.66% |
| 9 | Cisco Systems Inc | 1.56% |
| 10 | UnitedHealth Group Inc | 1.41% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 23.6% of the fund. See all top 25 holdings and asset mix →